KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Shares Outstanding (Weighted Average) (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $151.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 3.14% to $151.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $151.7 million through Dec 2025, up 3.14% year-over-year, with the annual reading at $151.7 million for FY2025, 3.14% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $151.7 million in Q4 2025 for Adaptive Biotechnologies, roughly flat from $152.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $152.4 million in Q3 2025 to a low of $139.0 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $144.9 million across 5 years, with a median of $144.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 10.24% in 2021 and later increased 1.07% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $140.4 million in 2021, then increased by 1.54% to $142.5 million in 2022, then increased by 1.31% to $144.4 million in 2023, then rose by 1.88% to $147.1 million in 2024, then grew by 3.14% to $151.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ADPT at $151.7 million in Q4 2025, $152.4 million in Q3 2025, and $150.6 million in Q2 2025.